- Home
- NCRA vs BCTX Comparison
NCRA vs BCTX Comparison
Compare NCRA & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- BCTX
- Stock Information
- Founded
- NCRA 2002
- BCTX 2014
- Country
- NCRA Taiwan
- BCTX Canada
- Employees
- NCRA N/A
- BCTX N/A
- Industry
- NCRA Farming/Seeds/Milling
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- BCTX Health Care
- Exchange
- NCRA Nasdaq
- BCTX Nasdaq
- Market Cap
- NCRA 23.0M
- BCTX 21.8M
- IPO Year
- NCRA N/A
- BCTX N/A
- Fundamental
- Price
- NCRA $1.39
- BCTX $10.08
- Analyst Decision
- NCRA
- BCTX Strong Buy
- Analyst Count
- NCRA 0
- BCTX 1
- Target Price
- NCRA N/A
- BCTX $40.00
- AVG Volume (30 Days)
- NCRA 2.0M
- BCTX 86.6K
- Earning Date
- NCRA 11-14-2025
- BCTX 12-15-2025
- Dividend Yield
- NCRA N/A
- BCTX N/A
- EPS Growth
- NCRA N/A
- BCTX N/A
- EPS
- NCRA N/A
- BCTX N/A
- Revenue
- NCRA $13,865,984.00
- BCTX N/A
- Revenue This Year
- NCRA N/A
- BCTX N/A
- Revenue Next Year
- NCRA N/A
- BCTX $380.95
- P/E Ratio
- NCRA N/A
- BCTX N/A
- Revenue Growth
- NCRA N/A
- BCTX N/A
- 52 Week Low
- NCRA $0.70
- BCTX $6.00
- 52 Week High
- NCRA $2.40
- BCTX $190.50
- Technical
- Relative Strength Index (RSI)
- NCRA 39.20
- BCTX 40.38
- Support Level
- NCRA $1.60
- BCTX $11.75
- Resistance Level
- NCRA $2.40
- BCTX $13.43
- Average True Range (ATR)
- NCRA 0.16
- BCTX 1.12
- MACD
- NCRA -0.01
- BCTX -0.50
- Stochastic Oscillator
- NCRA 12.03
- BCTX 8.18
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.